COMPANY INFO
EvolutionaryScale is a private company founded in 2023 and headquartered in New York City. It was founded by Nat Friedman, Daniel Gross, and others, employs between 11-50 people, and operates in the AI and biological modeling industry. The company develops frontier AI models for protein design that are used in drug discovery and materials science. Their website is evolutionaryscale.ai.
EvolutionaryScale is an innovative company founded in 2023 and based in New York City, specializing in research services within the fields of artificial intelligence and biological modeling. With a team of 11-50 employees, EvolutionaryScale is dedicated to developing cutting-edge AI models for protein design, which are used in drug discovery, materials science, and other applications that advance scientific understanding and medicine.
EvolutionaryScale funding history began with a remarkable seed round, raising a total of $142 million in its first year of operation. This significant influx of capital, obtained through a single round, highlights the confidence investors have in the company’s unique approach and its potential to disrupt bioengineering with AI. Key funding milestones include securing backing from high-profile venture capitalists, individual investors, and major industry players. EvolutionaryScale’s funding strategy focuses on accelerating scientific discovery through advanced AI models, supporting both research and industry partnerships in the biotech sector.
EvolutionaryScale’s seed round raised $142 million to propel the development of state-of-the-art AI models for protein generation. The funds are aimed at training next-generation artificial intelligence in biology and kickstarting collaborations with pharmaceutical and biotechnology companies.
Nat Friedman, former CEO of GitHub and an active venture capitalist, played a leading role in EvolutionaryScale funding as both a lead investor and strategic advisor, leveraging his technology expertise.
Daniel Gross, a renowned entrepreneur and investor, is a lead backer in EvolutionaryScale investors, contributing strategic insights as both a funder and advisor.
Lux Capital is a prominent venture capital firm focused on emerging technology in science. They participated as a lead investor in EvolutionaryScale funding rounds, supporting the company’s mission to transform AI-driven molecular discovery.
Amazon joined the EvolutionaryScale investment by providing both capital and potential partnership opportunities, reflecting confidence in the company’s AI infrastructure and commercial applications.
NVentures, the venture capital arm of NVIDIA, invested in EvolutionaryScale to accelerate the company’s progress in AI model training, hardware scaling, and scientific innovation.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching EvolutionaryScale funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.